{"medicine": "Risperidone", "atc": "N05AX08", "as_of": "2026-08-07T09:00:11Z", "active_in": ["AT", "DE", "ES", "EU", "FR", "GR", "IE", "IT", "SE"], "key_facts": ["As of 7 August 2026, Risperidone has active availability issues in 9 of 10 tracked European registers.", "Registers reporting issues: Austria, Germany, Spain, EU-wide (EMA), France, Greece, Ireland, Italy, Sweden.", "Latest expected-resolution date on file: 2027-06-30.", "Longest-running open report: since 2024-08-08 (24 months, Spain).", "Data source: 9 official medicines-agency registers, refreshed daily."], "records": [{"country": "AT", "product": "Risperidon \"ratiopharm\" 1 mg - Filmtabletten", "substance": "RISPERIDON", "status": "active", "reason": "", "start": "2026-02-26", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon 1A Pharma 1 mg - Filmtabletten", "substance": "RISPERIDON", "status": "limited", "reason": "", "start": "2026-07-22", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon Actavis 1 mg Filmtabletten", "substance": "RISPERIDON", "status": "limited", "reason": "", "start": "2026-07-21", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon Actavis 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "RISPERIDON", "status": "active", "reason": "", "start": "2025-07-08", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon Actavis 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "RISPERIDON", "status": "active", "reason": "", "start": "2025-07-08", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon Actavis 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "RISPERIDON", "status": "active", "reason": "", "start": "2025-06-17", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon Sandoz 1 mg - Filmtabletten", "substance": "RISPERIDON", "status": "limited", "reason": "", "start": "2026-07-31", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "RISPERIDON", "status": "active", "reason": "", "start": "2025-05-28", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon ratiopharm 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "RISPERIDON", "status": "active", "reason": "", "start": "2025-05-19", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "AT", "product": "Risperidon ratiopharm 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "RISPERIDON", "status": "active", "reason": "", "start": "2025-06-16", "expected_end": "", "alternatives": "", "url": "https://medikamente.basg.gv.at/de/medicine-shortage"}, {"country": "DE", "product": "Risperidon - 1 A Pharma 6 mg Filmtabletten", "substance": "Risperidon", "status": "active", "reason": "Erhöhte Nachfrage", "start": "2026-05-29", "expected_end": "2026-08-31", "alternatives": "Risperidon - 1 A Pharma 4 mg Filmtabletten - Einreichungsnummer: 2161026", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "DE", "product": "Risperidon AL 6 mg Filmtabletten", "substance": "Risperidon", "status": "active", "reason": "Erhöhte Nachfrage", "start": "2026-06-18", "expected_end": "2026-08-31", "alternatives": "N/A", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "DE", "product": "Risperidon Mylan 1 mg Filmtabletten", "substance": "Risperidon", "status": "active", "reason": "Probleme in der Herstellung", "start": "2026-06-02", "expected_end": "2027-04-15", "alternatives": "N/A", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "DE", "product": "Risperidon Mylan 2 mg Filmtabletten", "substance": "Risperidon", "status": "active", "reason": "Probleme in der Herstellung", "start": "2026-06-02", "expected_end": "2027-04-15", "alternatives": "N/A", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "DE", "product": "Risperidon Mylan 3 mg Filmtabletten", "substance": "Risperidon", "status": "active", "reason": "Probleme in der Herstellung", "start": "2026-06-02", "expected_end": "2027-04-15", "alternatives": "N/A", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "DE", "product": "Risperidon Mylan 4 mg Filmtabletten", "substance": "Risperidon", "status": "active", "reason": "Probleme in der Herstellung", "start": "2026-06-02", "expected_end": "2027-04-15", "alternatives": "N/A", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "DE", "product": "Risperidon-ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "Risperidon", "status": "active", "reason": "Probleme in der Herstellung", "start": "2024-09-05", "expected_end": "2026-09-30", "alternatives": "N/A", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "DE", "product": "Risperidon-ratiopharm 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "Risperidon", "status": "active", "reason": "Probleme in der Herstellung", "start": "2024-09-05", "expected_end": "2026-09-30", "alternatives": "N/A", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "DE", "product": "Risperidon-ratiopharm 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension", "substance": "Risperidon", "status": "active", "reason": "Probleme in der Herstellung", "start": "2024-09-05", "expected_end": "2026-09-30", "alternatives": "N/A", "url": "https://anwendungen.pharmnet-bund.de/lieferengpassmeldungen/faces/public/meldungen.xhtml"}, {"country": "ES", "product": "RISPERIDONA SANDOZ 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-03-22", "expected_end": "2026-09-29", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=652314"}, {"country": "ES", "product": "RISPERIDONA SANDOZ 3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-03-22", "expected_end": "2026-09-29", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=652306"}, {"country": "ES", "product": "RISPERIDONA SANDOZ 6 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-04-08", "expected_end": "2026-09-29", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=652290"}, {"country": "ES", "product": "RISPERIDONA TEVA 25 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG, 1 vial + 1 jeringa pregargada de disolvente + 1 adaptador vial + 2 agujas", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2024-08-26", "expected_end": "2026-12-30", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=730204"}, {"country": "ES", "product": "RISPERIDONA TEVA 37,5 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG, 1 vial + 1 jeringa pregargada de disolvente + 1 adaptador vial + 2 agujas", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2024-09-08", "expected_end": "2026-12-30", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=730205"}, {"country": "ES", "product": "RISPERIDONA TEVA 50 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG, 1 vial + 1 jeringa pregargada de disolvente + 1 adaptador vial + 2 agujas", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2024-08-08", "expected_end": "2026-12-30", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=730206"}, {"country": "ES", "product": "RISPERIDONA VIATRIS 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-06-10", "expected_end": "2027-03-23", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=667248"}, {"country": "ES", "product": "RISPERIDONA VIATRIS 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Distribución controlada por el titular.", "start": "2025-07-18", "expected_end": "2027-05-06", "alternatives": "", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=693482"}, {"country": "ES", "product": "RISPERIDONA VIATRIS 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-07-23", "expected_end": "2027-05-06", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=667258"}, {"country": "ES", "product": "RISPERIDONA VIATRIS 1 MG/ML SOLUCION ORAL EFG, 1 frasco de 100 ml", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-07-29", "expected_end": "2026-11-05", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=660432"}, {"country": "ES", "product": "RISPERIDONA VIATRIS 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Suministro sólo a hospitales.", "start": "2026-05-27", "expected_end": "2027-05-06", "alternatives": "", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=667266"}, {"country": "ES", "product": "RISPERIDONA VIATRIS 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-05-24", "expected_end": "2027-05-06", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=667271"}, {"country": "ES", "product": "RISPERIDONA VIATRIS 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-07-23", "expected_end": "2027-05-06", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=693472"}, {"country": "ES", "product": "RISPERIDONA VIATRIS 6 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos", "substance": "RISPERIDONA", "status": "active", "reason": "Existen otros medicamentos con el mismo principio activo y misma vía.", "start": "2026-04-16", "expected_end": "2027-05-06", "alternatives": "Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.", "url": "https://cima.aemps.es/cima/publico/detalle.html?nregistro=694930"}, {"country": "EU", "product": "Risperidone", "substance": "risperidone", "status": "active", "reason": "Schizophrenia", "start": "2025-11-19", "expected_end": "", "alternatives": "EMA lists available alternatives — see the EMA record.", "url": "https://www.ema.europa.eu/en/medicines/human/shortages/risperidone"}, {"country": "FR", "product": "Rispéridone 0,5 mg, 1 mg, 2 mg et 4 mg, comprimé orodispersible", "substance": "rispéridone", "status": "limited", "reason": "Psychiatrie", "start": "", "expected_end": "", "alternatives": "", "url": "https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments"}, {"country": "FR", "product": "Rispéridone 3 mg comprimé orodispersible", "substance": "rispéridone", "status": "active", "reason": "Psychiatrie", "start": "", "expected_end": "", "alternatives": "", "url": "https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments"}, {"country": "FR", "product": "Rispéridone L.P. 25 mg/2 ml, 37,5 mg/2 ml et 50 mg/2 ml, poudre et solvant pour suspension injectable à libération prolongée en seringue préremplie", "substance": "rispéridone", "status": "active", "reason": "Psychiatrie", "start": "", "expected_end": "", "alternatives": "", "url": "https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments"}, {"country": "GR", "product": "RUBRUM F.C.TAB 3MG/TAB BTX30 TABS (BLISTER)", "substance": "RISPERIDONE", "status": "limited", "reason": "ΕΛΛΑΔΑ διαδικασία περιεκτικότητας", "start": "2025-10-21", "expected_end": "2026-08-31", "alternatives": "TARGET PHARMA ΜΟΝΟΠΡΟΣΩΠΗ ΕΠΕ, Προβλήματα στην παραγωγική Εναλλακτικά άλλα σκευάσματα της", "url": "https://www.eof.gr/"}, {"country": "GR", "product": "RUBRUM F.C.TAB 4MG/TAB BTX30 TABS (BLISTER)", "substance": "RISPERIDONE", "status": "limited", "reason": "ΕΛΛΑΔΑ διαδικασία περιεκτικότητας", "start": "2025-10-21", "expected_end": "2026-08-31", "alternatives": "ARPOYA TABLET 15MG/TAB BTx28 tabs σε (PA/Alu foil Εναλλακτικά άλλα σκευάσματα της ίδιας δρ", "url": "https://www.eof.gr/"}, {"country": "IE", "product": "Perdamel 1 mg film-coated tablets", "substance": "Risperidone", "status": "active", "reason": "API shortage/unavailability (Ireland only)", "start": "2026-07-16", "expected_end": "2026-10-20", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.hpra.ie/find-a-medicine/for-human-use/medicine-shortages"}, {"country": "IE", "product": "Rispeva 0.5 mg film-coated tablets", "substance": "Risperidone", "status": "active", "reason": "Manufacturing delay (Multiple countries)", "start": "2026-07-13", "expected_end": "2026-07-30", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.hpra.ie/find-a-medicine/for-human-use/medicine-shortages"}, {"country": "IE", "product": "Rispeva 1 mg film-coated tablets", "substance": "Risperidone", "status": "active", "reason": "Manufacturing delay (Multiple countries)", "start": "2026-03-01", "expected_end": "2026-07-31", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.hpra.ie/find-a-medicine/for-human-use/medicine-shortages"}, {"country": "IE", "product": "Rispeva 1 mg film-coated tablets", "substance": "Risperidone", "status": "active", "reason": "Manufacturing delay (Global)", "start": "2026-06-01", "expected_end": "2026-07-31", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.hpra.ie/find-a-medicine/for-human-use/medicine-shortages"}, {"country": "IE", "product": "Rispeva 3 mg film-coated tablets", "substance": "Risperidone", "status": "active", "reason": "Manufacturing delay", "start": "2026-07-04", "expected_end": "2026-07-24", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.hpra.ie/find-a-medicine/for-human-use/medicine-shortages"}, {"country": "IE", "product": "Sperizak 25 mg powder and solvent for prolonged-release suspension for i", "substance": "Risperidone", "status": "active", "reason": "Manufacturing delay", "start": "2025-01-01", "expected_end": "", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.hpra.ie/find-a-medicine/for-human-use/medicine-shortages"}, {"country": "IE", "product": "Sperizak 37.5 mg powder and solvent for prolonged-release suspension for", "substance": "Risperidone", "status": "active", "reason": "Manufacturing delay", "start": "2025-01-01", "expected_end": "", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.hpra.ie/find-a-medicine/for-human-use/medicine-shortages"}, {"country": "IE", "product": "Sperizak 50 mg powder and solvent for prolonged-release suspension for i", "substance": "Risperidone", "status": "active", "reason": "Manufacturing delay", "start": "2025-01-01", "expected_end": "", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.hpra.ie/find-a-medicine/for-human-use/medicine-shortages"}, {"country": "IT", "product": "RISPERIDONE AUROBINDO", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2026-05-06", "expected_end": "", "alternatives": "AIFA: equivalents with the same active substance are available.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "IT", "product": "RISPERIDONE AUROBINDO", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2025-12-10", "expected_end": "", "alternatives": "AIFA: equivalents with the same active substance are available.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "IT", "product": "RISPERIDONE AUROBINDO PHARMA ITALIA", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2026-03-13", "expected_end": "", "alternatives": "AIFA: equivalents with the same active substance are available.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "IT", "product": "RISPERIDONE MYLAN PHARMA", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2026-09-01", "expected_end": "", "alternatives": "AIFA: equivalents with the same active substance are available.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "IT", "product": "RISPERIDONE MYLAN PHARMA", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2026-10-07", "expected_end": "", "alternatives": "AIFA: equivalents with the same active substance are available.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "IT", "product": "RISPERIDONE MYLAN PHARMA", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2026-09-05", "expected_end": "", "alternatives": "AIFA: equivalents with the same active substance are available.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "IT", "product": "RISPERIDONE TEVA GROUP", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2025-07-07", "expected_end": "", "alternatives": "AIFA: import of a foreign equivalent can be authorised.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "IT", "product": "RISPERIDONE TEVA GROUP", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2024-12-09", "expected_end": "", "alternatives": "AIFA: import of a foreign equivalent can be authorised.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "IT", "product": "RISPERIDONE TEVA GROUP", "substance": "RISPERIDONE", "status": "active", "reason": "Problemi produttivi", "start": "2025-09-19", "expected_end": "", "alternatives": "AIFA: import of a foreign equivalent can be authorised.", "url": "https://www.aifa.gov.it/farmaci-carenti"}, {"country": "SE", "product": "Risperidon Krka 1 mg Filmdragerad tablett", "substance": "risperidon", "status": "active", "reason": "", "start": "2026-03-19", "expected_end": "2026-08-06", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/forskrivning/lakemedelstillganglighet/sok-anmalda-forsaljningsuppehall"}, {"country": "SE", "product": "Risperidone Teva GmbH 25 mg Pulv. o. vätska t. inj.vätska, depotsusp.", "substance": "risperidon", "status": "active", "reason": "", "start": "2025-01-22", "expected_end": "2027-06-30", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/forskrivning/lakemedelstillganglighet/sok-anmalda-forsaljningsuppehall"}, {"country": "SE", "product": "Risperidone Teva GmbH 37,5 mg Pulv. o. vätska t. inj.vätska, depotsusp.", "substance": "risperidon", "status": "active", "reason": "", "start": "2024-08-29", "expected_end": "2027-06-30", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/forskrivning/lakemedelstillganglighet/sok-anmalda-forsaljningsuppehall"}, {"country": "SE", "product": "Risperidone Teva GmbH 50 mg Pulv. o. vätska t. inj.vätska, depotsusp.", "substance": "risperidon", "status": "active", "reason": "", "start": "2025-01-26", "expected_end": "2027-06-30", "alternatives": "Alternative(s) available — see the national register.", "url": "https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/forskrivning/lakemedelstillganglighet/sok-anmalda-forsaljningsuppehall"}], "page": "https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/risperidone/", "license": "cite as European Medicine Shortage Tracker (MobiDoctor)"}